跳至主要内容
临床试验/ISRCTN55552928
ISRCTN55552928已完成未知

Combination therapy with rheumatoid arthritis (COBRA)-light study, an open randomised trial comparing a modified COBRA therapy with the COBRA therapy according to treatment strategies for rheumatoid arthritis (BeSt) in early rheumatoid arthritis

Vrije University Medical Centre (VUMC) (The Netherlands)0 个研究点目标入组 160 人开始时间: 2008年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Active RA according to American College of Rheumatology (ACR) criteria
  • 2. Greater than six swollen joints or greater than six painful joints
  • 3. Disease duration less than two years
  • 4. Erythrocyte sedimentation rate (ESR) greater than 28 mm
  • 5. Visual analogue scale (VAS) greater than 20
  • 6. Age greater than 18 years, either sex

排除标准

  • 1. Prior treatment DMARDs (except hydroxychloroquine)
  • 2. Insulin-dependent diabetes mellitus
  • 3. Uncontrollable non-insulin dependent diabetes mellitus
  • 4. Heart failure New York Heart Association (NYHA) class 3 - 4
  • 5. Uncontrollable hypertension
  • 6. Alanine aminotransferase (ALT)/aspartate aminotransferase (AST) greater than three times normal values
  • 7. Reduced renal function (serum creatinine greater than 15 mcmol)
  • 8. Contra-indications for methotrexate, sulphasalazine or prednisolone
  • 9. Indications of probable tuberculosis

研究者

发起方
Vrije University Medical Centre (VUMC) (The Netherlands)

相似试验